Intestinal permeability in patients with acute myeloid leukemia.
Intestinal permeability was studied in patients with acute myeloid leukemia (AML) before, during and after chemotherapy. Intestinal permeability was determined by the lactulose (La)/mannitol (Ma) absorption test in 16 adult patients with de novo AML. The hydrogen breath test was used to disclose bacterial fermentation of the test substances in the small intestine. The permeability was found significantly increased (p<0.02) in the patients before induction chemotherapy treatment. During induction treatment and throughout the cytopenic period the intestinal permeability was constantly and significantly increased, compared with controls. In patients with abnormally increased permeability, no increase in hydrogen breath test result was noted. From our results it can be concluded that increased intestinal permeability is present in AML patients before commencing chemotherapy. Factors other than chemotherapy would seem to be more important regarding the occurrence of intestinal disturbances in these patients.
Sundström
G M
GM
Department of Medicine, Umeå University Hospital, Sweden.
Wahlin
A
A
Nordin-Andersson
I
I
Suhr
O B
OB
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D002199:Capillary Permeability / Q000502:physiology*; D005260:Female; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism / Q000503:physiopathology*; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D008297:Male; D008353:Mannitol / Q000378:metabolism*; D008875:Middle Aged
D000970:Antineoplastic Agents; D008353:Mannitol